Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

17 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Toward personalized sexual medicine (part 1): integrating the "dual control model" into differential drug treatments for hypoactive sexual desire disorder and female sexual arousal disorder.
Bloemers J, van Rooij K, Poels S, Goldstein I, Everaerd W, Koppeschaar H, Chivers M, Gerritsen J, van Ham D, Olivier B, Tuiten A. Bloemers J, et al. Among authors: van ham d, van rooij k. J Sex Med. 2013 Mar;10(3):791-809. doi: 10.1111/j.1743-6109.2012.02984.x. Epub 2012 Nov 6. J Sex Med. 2013. PMID: 23130782
Toward personalized sexual medicine (part 3): testosterone combined with a Serotonin1A receptor agonist increases sexual satisfaction in women with HSDD and FSAD, and dysfunctional activation of sexual inhibitory mechanisms.
van Rooij K, Poels S, Bloemers J, Goldstein I, Gerritsen J, van Ham D, van Mameren F, Chivers M, Everaerd W, Koppeschaar H, Olivier B, Tuiten A. van Rooij K, et al. Among authors: van ham d, van mameren f. J Sex Med. 2013 Mar;10(3):824-37. doi: 10.1111/j.1743-6109.2012.02982.x. Epub 2012 Nov 6. J Sex Med. 2013. PMID: 23130675 Clinical Trial.
Toward personalized sexual medicine (part 2): testosterone combined with a PDE5 inhibitor increases sexual satisfaction in women with HSDD and FSAD, and a low sensitive system for sexual cues.
Poels S, Bloemers J, van Rooij K, Goldstein I, Gerritsen J, van Ham D, van Mameren F, Chivers M, Everaerd W, Koppeschaar H, Olivier B, Tuiten A. Poels S, et al. Among authors: van ham d, van rooij k, van mameren f. J Sex Med. 2013 Mar;10(3):810-23. doi: 10.1111/j.1743-6109.2012.02983.x. Epub 2012 Nov 6. J Sex Med. 2013. PMID: 23130748 Clinical Trial.
Response to "toward personalized sexual medicine: where is the evidence?".
Tuiten A, Bloemers J, van Rooij K, Poels S, Gerritsen J, van Ham D, de Leede L, Everaerd W. Tuiten A, et al. Among authors: van rooij k. J Sex Med. 2014 Sep;11(9):2359-63. doi: 10.1111/jsm.12644. Epub 2014 Jul 22. J Sex Med. 2014. PMID: 25052951 No abstract available.
Efficacy and Safety of On-Demand Use of 2 Treatments Designed for Different Etiologies of Female Sexual Interest/Arousal Disorder: 3 Randomized Clinical Trials.
Tuiten A, van Rooij K, Bloemers J, Eisenegger C, van Honk J, Kessels R, Kingsberg S, Derogatis LR, de Leede L, Gerritsen J, Koppeschaar HPF, Olivier B, Everaerd W, Frijlink HW, Höhle D, de Lange RPJ, Böcker KBE, Pfaus JG. Tuiten A, et al. Among authors: van rooij k. J Sex Med. 2018 Feb;15(2):201-216. doi: 10.1016/j.jsxm.2017.11.226. Epub 2017 Dec 27. J Sex Med. 2018. PMID: 29289554 Free article. Clinical Trial.
17 results